Pathophysiological Role of Endothelin and Potential Therapeutic Targets for Receptor Antagonists
- 1 January 1998
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 197 references indexed in Scilit:
- Endothelin-1 Induces Increased Fibronectin Expression in Human Bronchial Epithelial CellsBiochemical and Biophysical Research Communications, 1996
- Expression of the Endothelin-Converting Enzyme Gene in Human TissuesBiochemical and Biophysical Research Communications, 1995
- Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in ratsLife Sciences, 1994
- Transient forebrain ischemia alters acutely endothelin receptor density and immunoreactivity in gerbil brainLife Sciences, 1993
- Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive modelLife Sciences, 1993
- BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injectionLife Sciences, 1993
- The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariaeBiochemical and Biophysical Research Communications, 1990
- Pathophysiological role of endothelin in acute renal failureLife Sciences, 1990
- Cyclosporine increases endothelin-1 binding site density in cardiac cell membranesBiochemical and Biophysical Research Communications, 1989
- Endothelin and the production of cerebral vasospasm in dogsBiochemical and Biophysical Research Communications, 1989